Promoter methylation assay of SASH1 gene in hepatocellular carcinoma

Journal of B.U.ON.

Volumn 19, Issue 4, 2014, Pages 1041-1047

  Peng, Liu ^a   Wei, He ^a   Liren, Li ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

DNA methylation; SASH1; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; PROTEIN; SASH 1 PROTEIN; UNCLASSIFIED DRUG; SASH1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84921927403     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011;140:1410-1426.
2. Jousilahti P, Salomaa V, Kuulasmaa K, Niemela M, Vartiainen E. Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women. J Epidemiol Community Health 2005;59:310-315.
3. Gray L, Batty GD, Craig P et al. Cohort profile: the Scottish health surveys cohort: linkage of study participants to routinely collected records for mortality, hospital discharge, cancer and offspring birth characteristics in three nationwide studies. Int J Epidemiol 2010;39:345-350.
4. Veeck J, Niederacher D, An H et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006;25:3479-3488.
5. Beaumont T, Leadbeater M. Treatment and care of patients with metastatic breast cancer. Nurs Stand 2011;25:49-56.
6. Dai C, Gu W. p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 2010;16:528-536.
7. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002;62:1008-1013.
8. Zhang H, Pan Y, Zheng L et al. FOXOl inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res 2011;71:3257-3267.
9. Zhao Y, Kong X, Li X et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 2011;6:e29363.
10. Narayan G, Freddy AJ, Xie D et al. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes Chromosomes Cancer 2011;50:1043-1053.
11. Zeller C, Hinzmann B, Seitz S et al. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene 2003;22:2972-2983.
12. Lee EY Muller WJ: Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol 2010;2:a003236.
13. Hesson LB, Dunwell TL, Cooper WN et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer 2009;8:42.
14. Rimkus C, Martini M, Friederichs J et al. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br J Cancer 2006;95:1419-1423.
15. Berdasco M, Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 2010;19:698-711.
16. Goeppert B, Schmezer P, Dutruel C et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010;52:2023-2033.
17. Banerjee D, Nandagopal K. Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-lc/LSF transcription factor in Down syndrome-related Alzheimer disease. Cell Mol Neurobiol 2007;27:1117-1126.
18. Dong S, Ying S, Kojima T et al. Crucial roles of MZF1 and Spl in the transcriptional regulation of the peptidylarginine deiminase type I gene (PADI1) in human keratinocytes. J Invest Dermatol 2008;128:549-557.
19. Luo X, Zhang X, Shao W, Yin Y, Zhou J. Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures. J Neurochem 2009;108:952-961.
20. Convertini P, Infantino V, Bisaccia F, Palmieri F, Iacobazzi V. Role of FOXA and Spl in mitochondrial acylcarnitine carrier gene expression in different cell lines. Biochem Biophys Res Commun 2011;404:376-381.
21. Kim HJ, Ko MS, Kim HK et al. Transcription factor Spl regulates basal transcription of the human DRG2 gene. Biochim Biophys Acta 2011;1809:184-190.
22. Gao SY, Li EM, Cui L et al. Spl and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells. I Biol Chem 2009;284:7995-8004.